Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Devices look on as Italy strengthens vigilance:

This article was originally published in Clinica

Executive Summary

Europe's medical devices industry will look closely at developments among its pharmaceutical counterparts, following the launch by the Italian health ministry of its national "weblinked sentinel" pharmacovigilance network. The project, which involves 1,000 family doctors, is linked to the EU-wide post-market initiative headed by the European Medicines Evaluation Agency. In the medical devices industry, too, there have been tentative moves at EU level to tighten post-market surveillance - an initiative led by the UK Medical Devices Agency. France, however, is alone in Europe in having established a formal device-related reporting network at local level, involving the official designation of incident reporters.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel